Evidence Explorer · MS-N223 · Supportive nutrition and feeding routes · Appraised November 3, 2026
A phase III trial closed early because many patients declined tube placement. Its limited results did not show less six-month weight loss with prophylactic nasogastric feeding; a reactive strategy was reasonable for most participants, with individualized exceptions.
Evidence at a glance
Benefit signal: No demonstrated advantage for routine prophylactic NGT placement
Certainty: Low because the trial stopped early
Risk context: Both delayed feeding and unnecessary tubes can cause harm
What was studied
The 2025 trial randomized patients 1:1 to nasogastric tube placement before radiotherapy or insertion only when required. Eighty-four patients were analyzed (40 prophylactic, 44 reactive); 39% of the reactive group ultimately required a tube.
Significant weight loss at six months occurred in 32.5% versus 15.9% (P=0.44). Median tube duration was 56 versus 47 days. Two-year progression-free and overall survival were also similar, but the trial was not adequately powered for these outcomes.
What this evidence cannot establish
Early closure and high refusal rates leave wide uncertainty. Results for nasogastric tubes do not automatically apply to prophylactic gastrostomy.
The record addresses feeding timing and route, not whether nutrition cures cancer or improves tumor response.
Practical safety context
NGTs can dislodge, cause discomfort and contribute to aspiration; gastrostomy has procedure, infection, leakage and long-term dependence risks. Delayed support can worsen malnutrition or interrupt treatment.
Swallowing assessment and continued safe oral intake, when possible, remain important to preserve function.
Questions for the care team
- What is my baseline weight loss, swallowing risk and expected radiation field?
- What exact trigger would prompt reactive tube placement?
- How will swallowing exercises and dietitian follow-up continue if a tube is used?
Sources
- Phase III prophylactic-versus-reactive NGT trial (PMID 40662454)
- Systematic review of feeding routes and timing (PMID 35244947)
Sources and publication status checked November 3, 2026. The trial was published in the December 2025 issue after July 15, 2025 online publication; early closure is explicitly retained.
For education, not personal medical advice. Nutrition and supplement decisions during cancer care should be individualized with the oncology and dietetics teams.
